Top Markets
Coin of the day
Kasten, Inc. Kasten, Inc.

Kasten, Inc.

KAST
Rank in Stocks #38075
Kasten, Inc., known commercially as DAKOTA Life Sciences, operates as a... Kasten, Inc., known commercially as DAKOTA Life Sciences, operates as a biopharmaceutical firm. Its primary endeavors involve obtaining, advancing, and bringing to market therapeutic agents crafted to avert and mitigate severe medical conditions prevalent in both hospital and general community environments. A significant aspect of its mission is to provide affordable and accessible pharmaceutical solutions, especially for individuals grappling with antimicrobial resistance. The company was founded in 1986 and is headquartered in Sioux Falls, South Dakota.
Share Price
$0.03
Last synced: 2025-06-23
Market Cap
$1.23M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Kasten, Inc. (KAST)
P/E ratio for Kasten, Inc. (KAST)
P/E ratio as of 2026 TTM: 0
According to Kasten, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Kasten, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.